Clinical trial
A Pilot Phase II Trial of Cabergoline in the Treatment of Metastatic Breast Cancer
NCT01730729 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Phase II Trial of Cabergoline in the Treatment of Metastatic Breast Cancer
- Lead sponsor
- Northwestern University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 11, 2013
- Completion date
- October 27, 2017
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent breast cancer, stage iv breast cancer